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Conventional mitral valve surgery is 
performed under cardioplegic arrest and aortic 
cross-clamp with a well-established efficacy and 
safety [1]. However, ischemia/ reperfusion injury 
remains a potential complication of the operation. 
Therefore, various methods and solutions have 
been developed to overcome the deleterious 
effects of ischemia/reperfusion injury [1–4]. These 
effects can be more prominent in patients with 
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Abstract 
Background: Various methods have been developed to overcome the deleterious 
effects of ischemia/ reperfusion injury that occurs after cardioplegic arrest. The aim 
of the study was to assess the safety, efficacy, and applicability of the beating-heart 
mitral valve replacement (MVR) compared to the conventional MVR. 
Methods: Forty patients scheduled for mitral valve replacement were randomly 
assigned into two groups, conventional MVR as the control group (n= 20) and 
beating-heart MVR with continuous antegrade coronary perfusion as the study 
group (n=20). Three patients in the beating-heart group were converted to the 
conventional technique because of the blood-flooded field and excluded from the 
analysis. 
Results: The preoperative clinical and echocardiographic variables were 
comparable between both groups. There was no significant difference between 
both groups regarding cardiopulmonary bypass time (79.4± 14 vs. 75.7± 10.9 
minutes; p= 0.398) and total operative time (200± 55.6 vs. 183.9± 67.5 min; p= 
0.458) in the conventional and beating-heart group, respectively. Serum troponin I 
level was significantly higher in the conventional MVR group 6 hours 
postoperatively (4.9±4 vs. 2.7±1.2 ng/ml; p= 0.036), while there was no significant 
difference between both groups regarding total CK and CK-MB (p= 0.565 & 0.597 
respectively).  Eight patients (44%) in the conventional MVR group needed inotropic 
support compared to 3 patients (19%) in the beating-heart MVR group (P = 0.11). 
There was no operative mortality or major morbidity in both groups. At 6-months 
follow-up, there was no difference in NYHA class (1.3±0.3 vs. 1.2±0.3; p= 0.336) and 
the ejection fraction (60.0±6.3 vs. 63.2±6 %; p= 0.139) in the conventional vs. 
beating-heart group.   
Conclusion: Beating-heart MVR is a safe alternative to the conventional method 
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impaired ventricular function and right ventricular 
hypertrophy. Lack of sufficient oxygen delivery to 
the myocardium during the ischemic period may 
lead to low cardiac output syndrome [1]. 
Recently, the use of the beating-heart 
technique was extended to valve surgery with 
satisfactory outcomes [1-4]. It seems reasonable 
to use on-pump beating heart technique for heart 
valve surgery if myocardial perfusion is 
maintained and particulate or air embolism is 
avoided. 
The advantage of beating mitral valve surgery 
is still debatable. The aim of this study was to 
assess the safety, efficacy, and applicability of the 
beating-heart mitral valve replacement (MVR) 
compared to the conventional MVR. 
Patients and Methods: 
This study is a randomized trial that was 
conducted in our center from March 2017 to April 
2019, after approval of the local Ethics Committee 
and written consent was obtained from all 
patients. 
Inclusion criteria were adult patients who had 
rheumatic or degenerative mitral valve disease 
scheduled for a mitral valve replacement with or 
without concomitant tricuspid valve intervention.  
We excluded patients who had concomitant 
procedures, and end-organ severe dysfunction, 
including hepatic failure, chronic renal failure, and 
previous stroke. Patients who had surgery for 
infective endocarditis and those with prior cardiac 
surgery were excluded.  
Computer-generated numbers randomly 
assigned patients into two groups: conventional 
MVR as the control group and beating-heart MVR 
with continuous coronary perfusion (CCP) as the 
study group. Fifty-eight patients were assessed for 
eligibility criteria; 18 of them were excluded 
before randomization (10 patients were not 
meeting inclusion criteria, and 8 declined to 
participate in the study). Three patients in the 
beating heart MVR group were converted to the 
conventional technique because of the blood-
flooded field and were excluded from the analysis. 
Three patients, two in the conventional MVR 
group and one in the beating-heart MVR group, 
were lost for follow-up and excluded from the 
analysis. (Figure 1) 
Preoperative evaluation included a detailed 
history, clinical examination, routine laboratory 
investigations and cardiac enzymes, 
electrocardiography (ECG), chest X-ray, and 
cardiac catheterization when indicated. 
Preoperative transthoracic echocardiography 
(TTE) was performed for all patients to assess 
mitral valve, tricuspid valve, left atrial dimension, 
pulmonary artery pressure, left ventricular end-
diastolic dimension (LVEDD), left ventricular end-
systolic dimension (LVESD), and left ventricular 
ejection fraction (EF). Preoperative 
transesophageal echocardiography (TEE) was 
done for 12 patients to assess the possibility of 
mitral valve repair. 
Operative procedures 
The standard general anesthetic technique for 
open-heart surgery with routine arterial and 
venous monitoring was used for both groups. A 
midline sternotomy approach was used for all 
patients. After full heparinisation, ascending 
aorta, superior and inferior vena cave cannulation 
were performed. The cardioplegic cannula was 
inserted in the ascending aorta as usual, and a 
vent was inserted through the right superior 
pulmonary vein into the left atrium. Then 
cardiopulmonary bypass (CPB) was established. 
The cardioplegic cannula in the beating-heart MVR 
group was connected through the insertion of a Y-
shaped line to the arterial perfusion line of the CPB 
pump oxygenator. 
Conventional MVR (control group): 
The ascending aorta was cross-clamped 
between the arterial perfusion cannula and the 
cardioplegic cannula with a vascular aortic clamp. 
Intermittent antegrade warm blood hyperkalemic 
cardioplegia was used, and repeated doses were 
administered every 20-25 minutes. Mean arterial 
pressure was maintained between 60 and 80 
mmHg with a pump flow rate between 2 - 2.5 L / 
min / m2. Mitral valve replacement using everting 
interrupted sutures with Teflon pledged with 
preservation of the posterior mitral leaflet was 
performed through the left atrial approach. 
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Figure 1: Study Flow Diagram
Bileaflet mechanical mitral valve prostheses were 
used in all patients. Concomitant tricuspid valve 
repair was done under beating heart for patients 
who had moderate or more tricuspid regurgitation 
(n= 9). Modified DeVega annuloplasty was used in 
all patients.  
Beating-heart MVR (study group): 
As in the conventional MVR group, ascending 
aorta was cross clamped between the arterial 
perfusion cannula and the cardioplegic cannula 
with a vascular aortic clamp after initiation of CPB, 
and the cavae were snared. Venting blood from 
the left side started through the right superior 
pulmonary vein vent that was inserted.  
Continuous perfusion of the coronary arteries was 
maintained with oxygenated blood from the CPB 
pump oxygenator through the connected 
“cardioplegic” cannula. Body temperature was 
kept at 36°C - 37°C, and the mean systemic 
pressure maintained above 60 - 80 mmHg with a 
pump flow rate between 2 - 2.5 L / min / m2. Aortic 
valve competency is essential for continuous 
perfusion of the coronary arteries.  
We used the transseptal approach for mitral 
valve replacement to avoid the tension of 
retraction on the atrial wall that may cause aortic 
incompetence and flooding the field with blood. 
The right atrium was opened longitudinally. A 
suction catheter was introduced to the right 
ventricle through the tricuspid valve to vent the 
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Table 1: Preoperative variables of the patients. Continuous variables are presented as mean ± SD and categorical 
variables as number and percent. 
Variables 
Conventional MVR Group 
(n=18) 





Mean ± SD 37.1±7.7 33.3±8.6 
0.193 
(range) 25-50 20-50 
Sex, Female 12(67%) 12(75%) 0.44 
NYHA 3.3±0.4 3.2±0.4 0.469 
Echo 
Data 
EF% 60±6.4 62.2±6.8 0.343 
LVEDD (cm) 5.5±0.9 5.3±0.9 0.519 
LVESD (cm) 3.7±0.8 3.5±0.8 0.469 
LA (cm) 5.8±1 5.4±0.8 0.20 
PASP (mmHg) 51.6±16.2 49.9±12.7 0.738 
MV 
Lesion 
MS 4(22%) 3(19%) 0.571 
MR 6(33%) 7(44%) 0.393 
MS and MR 8(45%) 6(37%) 0.476 
Rhythm 
Sinus 2(11%) 4(25%) 
0.271 
AF 16(89%) 12(75%) 
MVR = Mitral Valve Replacement, NYHA = New York Heart Association class, EF = Ejection Fraction, LVEDD 
= Left Ventricular End Diastolic Dimension, LVESD = Left Ventricular End Systolic Dimension, LA = Left Atrial 
Dimension, PASP = Pulmonary Artery Systolic Pressure, MS = Mitral Stenosis, MR = Mitral Regurgitation, AF 
= Atrial Fibrillation. 
right ventricle and to keep tricuspid valve 
incompetent.  Fossa ovale incised longitudinally, 
and the incision extended superiorly toward the 
superior vena cava and inferiorly to the area 
behind coronary sinus accessing the left atrium 
with direct exposure of the mitral valve. The 
interatrial septum was retracted with standard 
mitral retractor exposing the mitral valve. The 
venting catheter was redirected to the left 
ventricle through the mitral valve to vent the left 
ventricle and keep it empty.   
Mitral valve replacement with bileaflet 
mechanical mitral valve prosthesis was done with 
the heart beating. The technique of MVR was the 
same as that done in the conventional MVR group. 
With the beginning of fixing the prosthetic valve 
and tying its sutures, the vent was redirected to 
the left atrium, and the mitral valve prosthesis was 
kept open with a small-sized Foley catheter. After 
the fixation of the prosthetic valve, the left 
ventricle was filled with blood to extrude the air 
through the opening mitral valve prosthesis. 
Tricuspid annuloplasty was carried out with a 
modified DeVega technique for patients in 8 
patients. Cross clamp time, CPB time, and total 
operative time were recorded for all patients in 
both groups. 
Postoperative assessment 
Serum enzymes (total CK, CK-MB, and 
Troponin I) concentration were measured and 
recorded at 6 hours postoperatively for all 
patients. Duration of mechanical ventilation, 
inotropic support, total blood loss, units of blood 
transfused, duration of intensive care unit (ICU), 
and hospital stays were recorded for all patients. 
Postoperative complications that occurred during 
hospital stay were managed and recorded for all 
patients. Pre-discharge, trans-thoracic 
echocardiography (TTE) was done for all patients, 
and its data were recorded. The pre-discharge 
cardiac rhythm was recorded for all patients. 
Follow up 
Patients were followed-up for six months in 
the outpatient clinic, and TTE was done for all 
patients at six months postoperatively.
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Table 2: Intraoperative and postoperative data. Continuous variables are presented as mean ± SD and categorical 
variables as number and percent. 
Variables Conventional MVR Group 
(n=18) 












 Cross-clamp time, min 41.6±9.4 42.6±8 0.739 
CPB time, min 79.4±14 75.7±10.9 0.398 
















CK total (U/L) 632.5±119.6 654.9±106.4 0.565 
CK -MB (U/L) 57.6±36.4 52.6±14.8 0.597 
Troponin I (ng/ml) 4.9±4 2.7±1.2 0.036 
Need for Inotropic support 8(44%) 3(19%) 0.11 
Drain, ml 445±129.6 512.5±123.4 0.13 
Blood units  1.4±0.8 1.6±0.8 0.469 
Mechanical ventilation, hours 9±3.3 8.4±2.6 0.564 
I.C.U, days 2.2±0.4 2.1±0.2 0.352 
Hospital stay, days 12.3±1.8 12.2±3 0.91 
Ao= Aortic. CPB= cardiopulmonary bypass; CK total= total creatine phosphokinase; CK –MB = creatine- 
phosphokinase isoenzyme-muscle brain fraction; Drain = total blood loss in the drainage system; I.C.U = 
intensive care unit. 
Statistical Analysis 
Continuous variables were presented as mean 
± standard deviation (SD) and categorical variables 
as numbers and percentages. Chi-square test or 
Fischer Exact test if the frequency of the events 
was less than five were used for comparison 
between categorical variables and continuous 
variables were compared using t-test or Mann–
Whitney test if not normally distributed. The 
difference was considered significant at a p-value 
of less than 0.05. Analyses were done using IBM 
SPSS for Windows, Version 23.0 (IBM Corp. 
Chicago, IL USA). 
Results 
There was no significant difference in age (p = 
0.193), gender (p = 0.44) and NYHA class (p= 
0.469) between groups. (Table 1) Preoperative 
echocardiographic data were comparable 
between groups. (Table 1) Atrial fibrillation (AF) 
was the predominant rhythm in both groups with 
no significant difference (P = 0.271). (Table 1)
Table 3: Postoperative complications. Categorical variables are presented as number and percent. 
Variables 
Conventional MVR Group 
(n=18) 
Beating heart MVR 
Group (n=16) 
p-value 
PSVT 3(17%) 0 0.136 
Wound infection 1(5.5%) 1(6%) 0.727 
Re-exploration for bleeding    1(5.5%) 1(6%) 0.727 
Cerebrovascular stroke 0 1(6%) 0.47 
Prolonged mechanical ventilation 1(5.5%) 0 0.529 
Total 6(33%) 3(19%) 0.285 
Patients without complications 12(67%) 13(81%) 0.285 




Conversion from beating heart technique to 
the conventional technique occurred in 3 patients 
(15%); conversion occurred because the retraction 
to visualize the mitral valve induced aortic 
incompetence causing flooding the field with 
blood. The conversion was smooth without 
complication in the three patients.  
There was no significant difference between 
the conventional MVR group and beating heart 
MVR group regarding aortic cross-clamp, CPB 
time, and total operative time (P = 0.739, 0.398 
and 0.458 respectively). (Table 2) 
Postoperative outcomes 
Serum troponin I level was significantly higher 
in the conventional MVR group 6 hours 
postoperatively (P = 0.036). At the same time, 
there was no significant difference between both 
groups regarding total CK and CK-MB (p = 0.565 & 
0.597, respectively).  Forty-four percent of 
patients in the conventional MVR group needed 
inotropic support compared to only 19% in 
beating heart MVR group; however, there was no 
statistically significant difference (P = 0.11). 
(Table 2) 
There was no significant difference between 
both groups regarding total blood loss, duration 
of mechanical ventilation support, units of blood 
transfusion, duration of ICU, and hospital stay. 
(Table 3) 
In the conventional MVR group, one patient 
had re-exploration for bleeding (5.5%), 3 patients 
(17%) had paroxysmal supraventricular 
tachycardia (PSVT), one patient had superficial 
wound infection (5.5 %), and one patient (5.5%) 
had prolonged mechanical ventilation for more 
than 24 hours due to chest infection. In beating-
heart MVR group, one patient had re-exploration 
for bleeding (6%), one patient had superficial 
wound infection (6%), and one patient (6%) had a 
non-disabling cerebrovascular stroke (CVS). There 
was no significant difference between both groups 
regarding total numbers of complications (p = 
0.285). There was no mortality in both groups. 
Pre-discharge TTE 
Results showed no significant difference 
between both groups regarding EF (p = 0.15), 
LVEDD (P = 0.476), LVESD (P = 0.218), LA 
dimensions (P = 0.333) and PASP (P = 0.703). 
(Table 4) All mitral valve prostheses in both 
groups were well seated and well-functioning.  
There was no significant difference regarding 
cardiac rhythm between both groups (P = 0.271) 
with a predominance of AF rhythm (89% of 
patients in the conventional MVR group and 75% 
in beating heart MVR group). 
Follow-up 
Patients had regular follow-up visits in the 
outpatient clinic for six months postoperatively. 
Three patients, two in the conventional MVR 
group and one in beating heart MVR group, were 
lost for follow-up. TTE was done for all enrolled 
patients (n= 34) 6 months after surgery. There was 
no significant difference between both groups 
regarding left ventricular function and 
dimensions, left atrial dimension, and pulmonary 
artery systolic pressure. (Table 5) NYHA 
functional class improved in both groups as 
compared to preoperative values without 
significant difference between both groups (P = 
0.336). 
Discussion 
Beating heart techniques have expanded to 
include the mitral valve to decrease the risk of 
ischemic/reperfusion injury [5]. The technique 
may be of importance to those with left or right 
ventricular dysfunction who are more prone to 
myocardial damage during the ischemic time [6]. 
The on-pump beating-heart technique for heart 
valve surgery is feasible if myocardial perfusion is 
maintained, and particulate or air embolism is 
avoided [7,8].  
With a competent aortic valve, the heart 
continues to be perfused through the aortic root 
without clamping the ascending aorta. The left 
heart is kept empty and vented to the 
atmosphere, so there is a pressure gradient 
between aorta and left ventricle keeping the aortic 
valve closed, the heart beating, and left ventricle 
cannot push blood, air or particulate to aorta 
[8,9]. Morfa and coworkers [10] modified the 
technique by cross-clamping the ascending aorta 
between the aortic cannula and the cardioplegic 
cannula 
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Table 4: Pre-discharge echocardiography and cardiac rhythm. Continuous variables are presented as mean ± SD and 
categorical variables as number and percent. 
Variables 
Conventional MVR Group 
(n=18) 









EF (%) 59.0±5.9 62.1±6.2 0.15 
LVEDD (cm) 5.4±0.9 5.2±0.7 0.476 
LVESD (cm) 3.7±0.8 3.4±0.6 0.218 
LA (cm) 5.2±1.0 4.9±0.8 0.333 







Sinus 2(11%) 4(25%) 
0.271 
AF 16 (89%) 12(75%) 
ECHO= Echocardiography; EF=ejection fraction; LVEDD= left ventricular end-diastolic dimension; LVESD= 
left ventricular end-systolic dimension; LA= left atrial dimension; PASP = Pulmonary artery systolic 
pressure A. F= atrial fibrillation 
that connected to the arterial perfusion line of CPB 
pump oxygenator. Therefore, continuous 
perfusion of the coronary arteries is maintained 
with oxygenated blood from the CPB pump 
oxygenator. We used this modified technique in 
this study. With incompetent aortic valves, there 
is another option for doing valvular heart surgery 
on beating heart, using retrograde perfusion of 
the heart through the coronary sinus and cross-
clamping the ascending aorta with venting the 
aortic root [1, 7, 11].  
The surgical approach to the mitral valve is 
performed either using the conventional left 
atrial approach [3, 9, 12] or transseptal approach 
[1, 11, 13]. We used the transseptal approach in 
this study as recommended by Salerno and 
colleagues [13] because retraction of the left 
atrial wall during the trans-atrial approach often 
caused aortic insufficiency, for this reason, they 
shifted from trans-atrial to transseptal approach. 
Table 5: Six-month follow-up. Continuous variables are presented as mean ± SD and categorical variables as number 
and percent. 
Variables 
Conventional MVR Group 
(n=18) 









EF (%) 60.0±6.3 63.2±6 0.139 
LVEDD (cm) 4.9 ±0.8 4.8±0.7 0.697 
LVESD (cm) 3.3±0.7 3.1±0.5 0.342 
LA (cm) 4.8±1.0 4.3±1.2 0.204 







Sinus 2(11%) 4(25%) 
0.271 
AF 16(89%) 12(75%) 
NYHA 1.3±0.3 1.2±0.3 0.336 
ECHO= Echocardiography; EF=ejection fraction; LVEDD= left ventricular end-diastolic dimension; LVESD= 
left ventricular end-systolic dimension; LA= left atrial dimension; PASP = Pulmonary artery systolic 
pressure A. F= atrial fibrillation, NYHA = New York Heart Association class. 
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Although we used the transseptal approach 
for exposure of mitral valve, 3 patients (15%) in 
the beating heart MVR group were converted to 
the conventional technique with warm blood 
cardioplegia because of flooding the field with 
blood by induced aortic incompetence with 
retraction. The conversion was easy without 
complication.  Mo and coworkers [11] reported 
the conversion of 7 patients (2.8%), and Elsherif 
and collaborators [3] reported the conversion of 
one patient (3.3%) due to flooding the field with 
blood and difficulty to deal with the contracting 
annulus. With all efforts to obtain a bloodless field 
with the technique of beating-heart valve surgery, 
this approach still causes a relatively blood-filled 
field compared to conventional mitral valve 
surgery [14].   
Cellular damage markers, total CK, CK-MB, and 
troponin I, increased 6-hour postoperatively in 
both groups. There was no significant difference in 
the levels of total CK and CK-MB, but troponin I 
level was significantly lower in the beating-heart 
MVR group (P= 0.036). Our results coincide with 
the results of Katircioglu and colleagues [15] who 
reported significantly lower levels of CK-MB and 
troponin-T in the beating-heart group. Morfa and 
coworkers [10] reported lower levels of total CK 
and CK-MB in the beating group compared to the 
conventional group, despite the absence of a 
significant difference between the two groups. 
These results indicate that cellular damage always 
occurs due to CPB, regardless of the type of 
myocardial protection used, and there is lesser 
cellular damage with beating heart technique. This 
technique provides continuous perfusion of the 
cardiac muscles and avoids the effects of 
ischemia/reperfusion injury. 
In our study, 44% of the patients in the 
conventional MVR group needed inotropic 
support compared to 19% in the beating-heart 
MVR group. That coincides with the finding of 
Babaroglu and coworkers [9] who reported 35% 
vs 16% in the conventional group and beating 
group, respectively, and the findings reported by 
Katircioglu and co-investigators [15] who 
reported the 7.9% in the beating-heart mitral 
valve surgery needed inotropic support. The 
above results could 
be attributed to lesser cardiac cellular damage 
with beating heart surgery.  
In our study, there was no significant 
difference between both groups regarding aortic 
cross-clamp time, the total bypass time, and total 
operative time. However, the mean total 
operative time in the beating-heart group was 
lesser by about 16 minutes. These findings 
coincide with the results reported by Morfa and 
colleagues [10]. This finding can be explained by 
the absence of reperfusion time needed for 
support and weaning from CPB in the beating 
group. 
Katircioglu and coworkers [15] reported that 
cerebral stroke occurred in one (1.1%) patient. 
Salerno and colleagues [1] in a study of 291 
patients reported a 6.8% 30-day mortality rate, 
and 4 (1.3%) patients had a stroke. Pasic and 
coworkers [2] in their retrospective study on 120 
consecutive patients underwent beating-heart 
mitral valve surgery who were at high-risk for 
conventional mitral valve surgery reported no 
intraoperative deaths, a 7.5% 30-day mortality 
rate, and the main complications were prolonged 
mechanical ventilation (40%), pneumonia (25%), 
multiorgan failure (10%), acute kidney injury 
(7.5%) and disabling stroke  (2.5%). In our study, 
there was no operative mortality or major 
morbidity in both groups; one patient (6%) had a 
non-disabling cerebrovascular stroke in the 
beating group. These results coincide with the 
results reported by Morfa and coworkers [10], and 
this is because all the patients included in both 
studies were low surgical risk. 
Follow up of the patients at 6-months 
postoperatively showed improvement in NYHA 
functional class and the echocardiographic data in 
both groups without significant differences 
between them.  These improvements are mostly 
attributed to the replacement of the diseased 
mitral valve. 
Study limitations 
The study has several limitations, including the 
small number of patients and the exclusion of all 
high-risk patients. Additionally, the study 
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represents a single-center experience. A larger 
study in high-risk patients is recommended. 
Conclusion 
Beating mitral valve replacement with 
continuous antegrade perfusion of the coronary 
arteries without cardioplegia usage seems to be 
an acceptable alternative to the conventional 
technique. There is a relatively blood-filled field 
compared to the conventional technique. 
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